Suppr超能文献

用于产生疾病特异性抗体的抗原脂质体。

Antigenic Liposomes for Generation of Disease-specific Antibodies.

作者信息

Bednar Kyle J, Hardy Lakeya, Smeekens Johanna, Raghuwanshi Dharmendra, Duan Shiteng, Kulis Mike D, Macauley Matthew S

机构信息

Janssen R&D.

Department of Microbiology and Immunology, University of North Carolina; UNC Food Allergy Initiative, University of North Carolina.

出版信息

J Vis Exp. 2018 Oct 25(140):58285. doi: 10.3791/58285.

Abstract

Antibody responses provide critical protective immunity to a wide array of pathogens. There remains a high interest in generating robust antibodies for vaccination as well as understand how pathogenic antibody responses develop in allergies and autoimmune disease. Generating robust antigen-specific antibody responses is not always trivial. In mouse models, it often requires multiple rounds of immunizations with adjuvant that leads to a great deal of variability in the levels of induced antibodies. One example is in mouse models of peanut allergies where more robust and reproducible models that minimize mouse numbers and the use of adjuvant would be beneficial. Presented here is a highly reproducible mouse model of peanut allergy anaphylaxis. This new model relies on two key factors: (1) antigen-specific splenocytes are adoptively transferred from a peanut-sensitized mouse into a naïve recipient mouse, normalizing the number of antigen-specific memory B- and T-cells across a large number of mice; and (2) recipient mice are subsequently boosted with a strong multivalent immunogen in the form of liposomal nanoparticles displaying the major peanut allergen (Ara h 2). The major advantage of this model is its reproducibility, which ultimately lowers the number of animals used in each study, while minimizing the number of animals receiving multiple injections of adjuvant. The modular assembly of these immunogenic liposomes provides relatively facile adaptability to other allergic or autoimmune models that involve pathogenic antibodies.

摘要

抗体反应为多种病原体提供关键的保护性免疫。人们对于研发用于疫苗接种的强效抗体以及了解致病性抗体反应在过敏和自身免疫性疾病中如何发展仍有着浓厚兴趣。产生强效的抗原特异性抗体反应并非总是轻而易举的。在小鼠模型中,通常需要用佐剂进行多轮免疫,这会导致诱导抗体水平出现很大差异。一个例子是在花生过敏的小鼠模型中,若能有更强大且可重复的模型,将小鼠数量和佐剂的使用降至最低,那将是有益的。本文介绍了一种高度可重复的花生过敏过敏反应小鼠模型。这个新模型依赖于两个关键因素:(1)将抗原特异性脾细胞从花生致敏小鼠过继转移到未致敏的受体小鼠体内,使大量小鼠体内抗原特异性记忆B细胞和T细胞的数量标准化;(2)随后用展示主要花生过敏原(Ara h 2)的脂质体纳米颗粒形式的强效多价免疫原对受体小鼠进行加强免疫。该模型的主要优点是其可重复性,这最终减少了每项研究中使用的动物数量,同时将接受多次佐剂注射的动物数量降至最低。这些免疫原性脂质体的模块化组装为涉及致病性抗体的其他过敏或自身免疫模型提供了相对简便的适应性。

相似文献

5
Targeting CD22 on memory B cells to induce tolerance to peanut allergens.针对记忆 B 细胞上的 CD22 诱导对花生过敏原的耐受。
J Allergy Clin Immunol. 2022 Dec;150(6):1476-1485.e4. doi: 10.1016/j.jaci.2022.06.022. Epub 2022 Jul 14.

引用本文的文献

7
A single priming event prevents oral tolerance to peanut.单次致敏事件可预防花生口服耐受。
Clin Exp Allergy. 2023 Sep;53(9):930-940. doi: 10.1111/cea.14373. Epub 2023 Jul 12.
8
Induction of food-specific IgG by Gene Gun-delivered DNA vaccines.基因枪递送的DNA疫苗诱导食物特异性IgG
Front Allergy. 2022 Sep 19;3:969337. doi: 10.3389/falgy.2022.969337. eCollection 2022.
10
Peanut-Specific IgG4 and IgA in Saliva Are Modulated by Peanut Oral Immunotherapy.唾液中花生特异性 IgG4 和 IgA 受花生口服免疫治疗调节。
J Allergy Clin Immunol Pract. 2022 Dec;10(12):3270-3275. doi: 10.1016/j.jaip.2022.07.030. Epub 2022 Aug 6.

本文引用的文献

4
The role of autoantibodies in the pathophysiology of rheumatoid arthritis.自身抗体在类风湿关节炎病理生理学中的作用。
Semin Immunopathol. 2017 Jun;39(4):437-446. doi: 10.1007/s00281-017-0627-z. Epub 2017 Apr 27.
6
Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults.用于治疗儿童和青年花生过敏的经皮免疫疗法。
J Allergy Clin Immunol. 2017 Apr;139(4):1242-1252.e9. doi: 10.1016/j.jaci.2016.08.017. Epub 2016 Oct 26.
9
Analysis of allergic immune responses in humanized mice.人源化小鼠的过敏性免疫反应分析。
Cell Immunol. 2016 Oct;308:7-12. doi: 10.1016/j.cellimm.2016.07.008. Epub 2016 Jul 15.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验